FIELD: chemistry.
SUBSTANCE: in novel tocopherol-modified therapeutic drug compounds of formula 1 T-L-D, T is tocopherol, L is succinate, and D is camptotecin or its derivative, where all three fragments are bound covalently. Invention also relates to emulsions based on said compounds, formulations of micelles, including said compounds, methods of treating cell proliferative disease using said compounds and formulations, as well as to said compounds application for production of medication for treatment of cell proliferative disease.
EFFECT: increase of composition and treatment method efficiency.
18 cl, 17 dwg, 4 tbl, 19 ex
Title | Year | Author | Number |
---|---|---|---|
CAMPTOTECIN DERIVATIVES AND APPLICATION THEREOF | 2007 |
|
RU2411244C2 |
CARBOCYCLIC ANALOGS OF 20(S)-CAMPTOTHECIN, METHODS OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT | 1997 |
|
RU2200163C2 |
PROTEIN-TARGETED COMPOUNDS, THEIR COMPOSITIONS, METHODS AND APPLICATIONS | 2016 |
|
RU2694895C2 |
DELIVERY SYSTEMS FOR CONTROLLED DRUG RELEASE | 2016 |
|
RU2748992C2 |
PROLYL HYDROXYLASE INHIBITORS | 2010 |
|
RU2518071C2 |
TETRAHYDRONAPHTHALENE AND TETRAHYDROISOQUINOLINE DERIVATIVES AS ESTROGEN RECEPTOR DESTROYERS | 2017 |
|
RU2797244C2 |
ETOPOSIDE AND DOXORUBICIN CONJUGATES FOR DRUG DELIVERY | 2009 |
|
RU2531591C2 |
COMPOUNDS FOR TREATING COMPLEMENT-MEDIATED DISORDERS | 2015 |
|
RU2703995C2 |
SYNTHESIS OF POLYMER CONJUGATES OF INDOLOCARBAZOLE COMPOUNDS | 2009 |
|
RU2532341C2 |
CAMPTOTHECIN DERIVATIVES, POSSESSING ANTITUMOUR ACTIVITY | 2012 |
|
RU2561118C2 |
Authors
Dates
2008-12-10—Published
2004-10-29—Filed